Q2 revenue was $96.2B, up 18% QoQ and 106% YoY, with $64B operating income and $26B returned to shareholders. Jensen Huang says AI demand is accelerating, multiple frontier labs are scaling in parallel, and Vera Rubin is in full production — implying continued revenue strength. The underlying business is extremely strong, so any post-earnings weakness may be a watch-and-buy opportunity rather than a reason to sell. Despite blowout numbers, the stock dropped about 3% after earnings and is up only 9% YTD vs QQQ’s 16%, suggesting expectations are already high.
Q2 revenue was $96.2B, up 18% QoQ and 106% YoY, with $64B operating income and $26B returned to shareholders. Jensen Huang says AI demand is accelerating, multiple frontier labs are scaling in parallel, and Vera Rubin is in full production — implying continued revenue strength. The underlying business is extremely strong, so any post-earnings weakness may be a watch-and-buy opportunity rather than a reason to sell. Despite blowout numbers, the stock dropped about 3% after earnings and is up only 9% YTD vs QQQ’s 16%, suggesting expectations are already high.